XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 7,423,324 $ 6,183,508
General and administrative 3,004,135 3,210,357
Loss from operations (10,427,459) (9,393,865)
Other income (expense):    
Interest income 981,487 1,810,269
Interest expense (483,529) (498,526)
Total other income, net 497,958 1,311,743
Net loss $ (9,929,501) $ (8,082,122)
Net loss per share - basic $ (0.17) $ (0.14)
Net loss per share - diluted $ (0.17) $ (0.14)
Weighted average common shares outstanding - basic 59,887,277 59,414,489
Weighted average common shares outstanding - diluted 59,887,277 59,414,489